Literature DB >> 10621531

The status of hyperopic laser-assisted in situ keratomileusis.

D P O'Brart1.   

Abstract

The development of excimer laser technology, coupled with advances in lamellar corneal surgery, has heralded a new era in the treatment of refractive errors. This paper discusses the current status of hyperopic laser-assisted in situ keratomileusis. This surgical modality is at a relatively early stage of investigation but appears to offer promise for the surgical correction of hyperopia. This paper considers the evolution of the technique, analyzes the current literature, and discusses the current indications, limitations, and possible future developments.

Entities:  

Mesh:

Year:  1999        PMID: 10621531     DOI: 10.1097/00055735-199908000-00005

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  5 in total

1.  [Laser in situ keratomileusis for correction of hyperopia and hyperopic astigmatism using a scanning spot excimer laser. Results of a prospective clinical study after 1 year].

Authors:  T Kohnen; A Mirshahi; M Cichocki; J Bühren; G W K Steinkamp
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Long-Term Followup of Laser In Situ Keratomileusis for Hyperopia Using a 213 nm Wavelength Solid-State Laser.

Authors:  Carmina Franz G Quito; Archimedes Lee D Agahan; Raymond P Evangelista
Journal:  ISRN Ophthalmol       Date:  2013-03-03

3.  Assessment of refractive outcome of femtosecond-assisted LASIK for hyperopia correction.

Authors:  Mohamed Tarek El-Naggar; Dikran Gilbert Hovaghimian
Journal:  Electron Physician       Date:  2017-03-25

4.  Patient satisfaction and self-reported dry eye symptoms in hyperopic patients treated with femtosecond laser in situ keratomileusis.

Authors:  Petri Mäkinen; Anne Huhtala; Juhani Pietilä; Janika Nättinen; Teppo Rajala; Kalle Salmenhaara; Magomed Udratov; Hannu Uusitalo
Journal:  Clin Ophthalmol       Date:  2019-04-26

5.  Correction of hyperopia by intrastromal cutting and liquid filler injection.

Authors:  Sebastian Freidank; Alfred Vogel; R Rox Anderson; Reginald Birngruber; Norbert Linz
Journal:  J Biomed Opt       Date:  2019-05       Impact factor: 3.170

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.